Corpovael SA de CV Class A

As of June 30, 2026, Corpovael SA de CV Class A carries a market capitalization of 2.19B, placing it among publicly traded companies globally. Its enterprise value stands at 4.53B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Corpovael SA de CV Class A's next confirmed earnings release is scheduled for February 23, 2027.

As of June 30, 2026, Corpovael SA de CV Class A has 292.64M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Corpovael SA de CV Class A maintains a current ratio of 2.37, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Corpovael SA de CV Class A recorded 66.00M in income tax expense.

As of the close on October 23, 2026, Corpovael SA de CV Class A's stock has gained approximately 88.41% over the past 52 weeks. The 50-day moving average sits at 7.39, while the 200-day moving average is 6.90.

As of June 30, 2026, Corpovael SA de CV Class A holds 435.06M in cash and equivalents against 2.72B in total debt, resulting in a net debt position of 2.28B. Total book value stands at 5.85B, with working capital of 3.87B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.